Introduction:

Myocardial infarction is one of the diseases that cause the most deaths worldwide. Studies show that, in patients with acute myocardial infarction, early percutaneous reperfusion (angioplasty) has better outcomes than isolated medical treatment in ventricular function, functional class, and early and late mortality.

Objective:

To predict short-term death in patients with acute myocardial infarction who have been received angioplasty.

Methods:

Retrospective and cross-sectional research, whose data was collected from medical records at a cardiology center in Ecuador. The sample consisted of 50 patients who met the inclusion criteria, whose data were assessed according the CADILLAC risk score, used as an instrument, taking into account survival at thirty days after the procedure.

Results:

The mortality rate at 30 days was 22%, of which 32.3% belonged to the age group over 65 years. The most influential mortality predictors were left ventricular ejection fraction (LVEF) under 40% (73.3%), final flow of thrombolysis in myocardial infarction (TIMI) under grade 2 (46.1%), anemia (66.6%), and the presence of heart failure (42,3 %).

Conclusion:

The CADILLAC risk score is an important predictor for mortality. Anemia should be taken into account as a mortality predictor.

        · resumen en Español     · texto en Español     · Español ( pdf )